Eli Lilly (LLY) Dividends Paid - Common (2009 - 2026)

Eli Lilly (LLY) posted Dividends Paid - Common of $1.5 billion for Q1 2026, up 15.05% quarter-over-quarter from $1.3 billion in Q4 2025, and up 15.01% year-on-year from $1.3 billion in Q1 2025.

Eli Lilly (LLY) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Eli Lilly (LLY) has reported Dividends Paid - Common for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

  • Dividends Paid - Common for Q1 2026 came in at $1.5 billion, up 15.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 15.01% YoY), and the FY2025 annual result was $5.4 billion, up 15.04% from the prior year.
  • Dividends Paid - Common was $1.5 billion for Q1 2026 at Eli Lilly, up from $1.3 billion in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $2.0 billion in Q2 2023 and troughed at $882.2 million in Q3 2022.
  • Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
  • Year-over-year, Dividends Paid - Common slumped 42.36% in 2024 and gained 15.21% in 2025.
  • Over 5 years, Dividends Paid - Common stood at $884.4 million in 2022, then advanced by 15.08% to $1.0 billion in 2023, then advanced by 14.75% to $1.2 billion in 2024, then advanced by 15.21% to $1.3 billion in 2025, then rose by 15.05% to $1.5 billion in 2026.
  • Per Business Quant data, the three most recent Dividends Paid - Common figures were $1.5 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.55 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 3.13 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.09 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.29 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.11 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.04 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.45 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.55 Bn
Mar 31, 2026 1.55 Bn
Dec 31, 2025 1.35 Bn
Dec 31, 2025 1.35 Bn
Sep 30, 2025 1.35 Bn
Sep 30, 2025 1.35 Bn
Jun 30, 2025 1.35 Bn
Jun 30, 2025 1.35 Bn
Mar 31, 2025 1.35 Bn
Mar 31, 2025 1.35 Bn
Dec 31, 2024 1.17 Bn
Dec 31, 2024 1.17 Bn
Sep 30, 2024 1.17 Bn
Sep 30, 2024 1.17 Bn
Jun 30, 2024 1.17 Bn
Jun 30, 2024 1.17 Bn
Mar 31, 2024 1.17 Bn
Mar 31, 2024 1.17 Bn
Dec 31, 2023 1.02 Bn
Dec 31, 2023 1.02 Bn